| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_714c6ba69ccfabf04f3b2ea0f110b94a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d0446a5bd77c7da68216fc2e3f05d48 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2018-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81938f411254f41205c6057f87e83a3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc7bf8dd4074946b80c31cc480966caf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dede08e446863c1d6c8a642e9dd57cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92cd72151f89e1a44c969e99ff9123d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c042902d9b9c54b923bf906839f74fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0e6984ccc374afefb9fde0fb9147452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b092501b6f2597cd4ccbeebb5d65a163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcd3fae267600bd730be2cc082e1ed86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3744aa5f7fa31217a6b89e076dd5ef88 |
| publicationDate |
2020-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200056999-A |
| titleOfInvention |
How to diagnose and treat lung cancer |
| abstract |
A method for diagnosing lung cancer in a subject in need of diagnosis of lung cancer is provided. The method is: (a) providing a biological sample of the subject, including peripheral blood mononuclear cells (PBMC); (b) contacting the PBMC in vitro with a stimulant selected from the group consisting of stimulants listed in Tables 3 and 4; And (c) measuring the metabolic activity of the PBMC contacted according to (b), wherein a statistically significant change in the metabolic activity of the PBMC when compared to a control sample indicates lung cancer It is a lung cancer diagnostic method, including; |
| priorityDate |
2017-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |